{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T14:52:22Z","timestamp":1789138342317,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.jcv.2022.105079","type":"journal-article","created":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T12:13:58Z","timestamp":1641384838000},"page":"105079","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Treatment for Epstein-Barr Virus-associated uveitis confirmed by polymerase chain reaction: Efficacy of Anti-Viral Agents and a literature review"],"prefix":"10.1016","volume":"147","author":[{"given":"Sukhum","family":"Silpa-archa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wararee","family":"Sriyuttagrai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C Stephen","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jcv.2022.105079_bib0001","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1080\/09273948.2019.1611877","article-title":"nodular necrotizing-scleritis associated with Epstein-Barr virus infection: a case report","volume":"28","author":"Bustos-Mejia","year":"2020","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.jcv.2022.105079_bib0002","first-page":"213","article-title":"A case report of Epstein-Barr virus-associated retinal vasculitis: successful treatment using only acyclovir therapy","volume":"9","author":"Keorochana","year":"2016","journal-title":"Int. Med. Case Rep. J"},{"issue":"1","key":"10.1016\/j.jcv.2022.105079_bib0003","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12886-019-1090-5","article-title":"Bilateral granulomatous panuveitis in two patients with T-cell type of chronic active Epstein-Barr virus infection","volume":"19","author":"Takahashi","year":"2019","journal-title":"BMC Ophthalmol."},{"issue":"31","key":"10.1016\/j.jcv.2022.105079_bib0004","doi-asserted-by":"crossref","first-page":"e11663","DOI":"10.1097\/MD.0000000000011663","article-title":"Retinitis associated with double infection of Epstein-Barr virus and varicella-zoster virus: a case report","volume":"97","author":"Sato","year":"2018","journal-title":"Medicine (Baltimore)."},{"key":"10.1016\/j.jcv.2022.105079_bib0005","article-title":"Bilateral acute retinal necrosis caused by two separate viral etiologies","volume":"18","author":"Williams","year":"2020","journal-title":"Am. J. Ophthalmol. Case Rep"},{"issue":"4","key":"10.1016\/j.jcv.2022.105079_bib0006","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1080\/09273948.2019.1609047","article-title":"Successful treatment of necrotizing retinitis with Epstein-Barr virus-positive ocular fluid by intravitreal methotrexate injection","volume":"28","author":"Mashima","year":"2020","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"1","key":"10.1016\/j.jcv.2022.105079_bib0007","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000445372","article-title":"Acute retinal necrosis associated with Epstein-Barr virus in a patient undergoing immunosuppressive therapy","volume":"7","author":"Oe","year":"2016","journal-title":"Case Rep. Ophthalmol"},{"issue":"7","key":"10.1016\/j.jcv.2022.105079_bib0008","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/jamaophthalmol.2014.266","article-title":"Acute retinal necrosis associated with Epstein-Barr virus: immunohistopathologic confirmation","volume":"132","author":"Schaal","year":"2014","journal-title":"JAMA Ophthalmol."},{"issue":"2","key":"10.1016\/j.jcv.2022.105079_bib0009","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2147\/OPTH.S1757","article-title":"Epstein-Barr virus and acute retinal necrosis in a 5-year-old immunocompetent child","volume":"2","author":"Gallego-Pinazo","year":"2008","journal-title":"Clin. Ophthalmol"},{"key":"10.1016\/j.jcv.2022.105079_bib0010","article-title":"Epstein-Barr virus acute retinal necrosis in an immunocompetent host","author":"Chan","year":"2018","journal-title":"Retin. Cases Brief Rep"},{"issue":"7","key":"10.1016\/j.jcv.2022.105079_bib0011","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1001\/archopht.121.7.1047","article-title":"Epstein-Barr virus-related bilateral acute retinal necrosis in a patient with X-linked lymphoproliferative disorder","volume":"121","author":"Hershberger","year":"2003","journal-title":"Arch. Ophthalmol."},{"issue":"4","key":"10.1016\/j.jcv.2022.105079_bib0012","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF03260091","article-title":"Real-time Epstein-Barr virus PCR for the diagnosis of primary EBV infections and EBV reactivation","volume":"9","author":"Luderer","year":"2005","journal-title":"Mol. Diagn."},{"issue":"6","key":"10.1016\/j.jcv.2022.105079_bib0013","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1002\/cncr.20099","article-title":"Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A\/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma","volume":"100","author":"Shao","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.jcv.2022.105079_bib0014","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.2147\/OPTH.S174694","article-title":"Herpesviridae prevalence in aqueous humor using PCR","volume":"12","author":"Keorochana","year":"2018","journal-title":"Clin. Ophthalmol"},{"issue":"1","key":"10.1016\/j.jcv.2022.105079_bib0015","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1386-6532(00)00069-X","article-title":"Virological diagnosis of herpes simplex encephalitis","volume":"17","author":"Sauerbrei","year":"2000","journal-title":"J. Clin. Virol."},{"issue":"7","key":"10.1016\/j.jcv.2022.105079_bib0016","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1136\/bjo.2007.133967","article-title":"Use of multiplex PCR and real-time PCR to detect human herpes virus genome in ocular fluids of patients with uveitis","volume":"92","author":"Sugita","year":"2008","journal-title":"Br. J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.jcv.2022.105079_bib0017","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1136\/bjo.82.3.245","article-title":"Increased presence of Epstein-Barr virus DNA in ocular fluid samples from HIV negative immunocompromised patients with uveitis","volume":"82","author":"Ongkosuwito","year":"1998","journal-title":"Br. J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.jcv.2022.105079_bib0018","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1080\/09273948.2020.1760549","article-title":"Epstein-Barr Virus and the eye","volume":"28","author":"Cunningham","year":"2020","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"3","key":"10.1016\/j.jcv.2022.105079_bib0019","doi-asserted-by":"crossref","first-page":"748","DOI":"10.4314\/ahs.v15i3.7","article-title":"Polymerase chain reaction to search for Herpes viruses in uveitic and healthy eyes: a South African perspective","volume":"15","author":"Laaks","year":"2015","journal-title":"Afr. Health Sci."},{"issue":"1","key":"10.1016\/j.jcv.2022.105079_bib0020","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1080\/09273948.2017.1406957","article-title":"Polymerase chain reaction and Goldmann-Witmer coefficient to examine the role of Epstein-Barr virus in Uveitis","volume":"27","author":"Smit","year":"2019","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.jcv.2022.105079_bib0021","article-title":"Antiviral agents for infectious mononucleosis (glandular fever)","volume":"12","author":"De Paor","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"issue":"4","key":"10.1016\/j.jcv.2022.105079_bib0022","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1080\/09273948.2019.1606258","article-title":"Epstein-Barr Virus-associated Hemophagocytic Lymphohistiocytosis following cyclosporine for Uveitis","volume":"28","author":"Chen","year":"2020","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"1","key":"10.1016\/j.jcv.2022.105079_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/ICB.0b013e3181babf1f","article-title":"Epstein-barr infection of the retina: case report and review of the literature","volume":"5","author":"Kim","year":"2011","journal-title":"Retin. Cases Brief Rep"},{"issue":"6","key":"10.1016\/j.jcv.2022.105079_bib0024","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1016\/j.jcjo.2012.07.011","article-title":"Positive Epstein-Barr virus polymerase chain reaction in a case of acute retinal necrosis","volume":"47","author":"Hamam","year":"2012","journal-title":"Can. J. Ophthalmol."},{"issue":"7","key":"10.1016\/j.jcv.2022.105079_bib0025","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/eye.2013.66","article-title":"Identification of Epstein-Barr virus in a case of aggressive retinochoroiditis","volume":"27","author":"Schmoll","year":"2013","journal-title":"Eye (Lond)"},{"issue":"Pt 6","key":"10.1016\/j.jcv.2022.105079_bib0026","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/eye.2001.254","article-title":"Severe bilateral panuveitis in a patient with asymptomatic Epstein-Barr virus infection","volume":"15","author":"Heiligenhaus","year":"2001","journal-title":"Eye (Lond)"},{"issue":"1","key":"10.1016\/j.jcv.2022.105079_bib0027","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s12886-020-01583-x","article-title":"Case of primary intraocular lymphoproliferative disorder caused by Epstein-Barr Virus","volume":"20","author":"Ban","year":"2020","journal-title":"BMC Ophthalmol."},{"issue":"4","key":"10.1016\/j.jcv.2022.105079_bib0028","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0161-6420(96)30632-5","article-title":"Detection of Epstein-Barr virus genome in ocular tissues","volume":"103","author":"Chodosh","year":"1996","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.jcv.2022.105079_bib0029","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s00705-005-0686-7","article-title":"High incidence of elevated antibody titers to Epstein-Barr virus in patients with uveitis","volume":"151","author":"Touge","year":"2006","journal-title":"Arch. Virol."},{"issue":"1","key":"10.1016\/j.jcv.2022.105079_bib0030","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1080\/09273948.2018.1543709","article-title":"The Usefulness of aqueous fluid Analysis for Epstein-Barr virus in patients with Uveitis","volume":"28","author":"Groen-Hakan","year":"2020","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"10","key":"10.1016\/j.jcv.2022.105079_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2009.03.029","article-title":"Acute retinal necrosis: clinical features, early vitrectomy, and outcomes","volume":"116","author":"Hillenkamp","year":"2009","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.jcv.2022.105079_bib0032","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1080\/09273948.2017.1370653","article-title":"Polymerase chain reaction and Goldmann-Witmer coefficient to examine the role of Epstein-Barr virus in Uveitis","volume":"27","author":"Smit","year":"2019","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.jcv.2022.105079_bib0033","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/509296","article-title":"Advances in virus-directed therapeutics against Epstein-Barr virus-associated Malignancies","volume":"2012","author":"Ghosh","year":"2012","journal-title":"Adv. Virol"},{"issue":"4","key":"10.1016\/j.jcv.2022.105079_bib0034","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.ophtha.2006.08.037","article-title":"Acute retinal necrosis features, management, and outcomes","volume":"114","author":"Lau","year":"2007","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.jcv.2022.105079_bib0035","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.ajo.2010.05.015","article-title":"Identification of new pathogens in the intraocular fluid of patients with uveitis","volume":"150","author":"de Groot-Mijnes","year":"2010","journal-title":"Am. J. Ophthalmol."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653222000154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653222000154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T03:15:50Z","timestamp":1761362150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653222000154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":35,"alternative-id":["S1386653222000154"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2022.105079","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment for Epstein-Barr Virus-associated uveitis confirmed by polymerase chain reaction: Efficacy of Anti-Viral Agents and a literature review","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2022.105079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105079"}}